Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marc Treluyer

Showing results (21-30 of 171) with videos related to

Pageof 18
Sort By:
Kidney International|March 1, 2021
Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case-noncase studyLaurent Chouchana, Laure-Hélène Preta, Mylène Tisseyre, et al.
British Journal of Clinical Pharmacology|February 17, 2022
Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273)Laure-Hélène Préta, Adrien Contejean, Francesco Salvo, et al.
Obstetrics and Gynecology|December 1, 2025
In ReplyMathis Collier, Pierre Hannoun, Valérie Cormier-Daire, et al.
Therapie|November 26, 2023
Drug-induced fetal and offspring disorders, beyond birth defectsMargaux Louchet, Mylène Tisseyre, Florentia Kaguelidou, et al.
British Journal of Clinical Pharmacology|May 23, 2023
Azathioprine-induced vanishing bile duct syndrome: The value of early thiopurine metabolism assessmentLaurent Chouchana, Benoit Terris, Philippe Sogni, et al.
Allergy, Asthma & Immunology Research|March 18, 2021
Safety of Omalizumab During Pregnancy and Breast-Feeding With Assessment of Placental Transfer: A Case ReportDoriane Majou, Baptiste Moreira, Clémence Martin, et al.
Journal of the American Academy of Dermatology|May 30, 2021
Drug-induced eosinophilic fasciitis: A dual pharmacovigilance analysisAlexandre Teboul, Laurent Chouchana, Geneviève Durrieu, et al.
Rheumatology (Oxford, England)|October 9, 2021
Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance studyCamille Mettler, Annie-Pierre Jonville-Bera, Aurélie Grandvuillemin, et al.
Current Pharmaceutical Design|March 21, 2019
Methodological Approaches to Evaluate Fetal Drug ExposureNaïm Bouazza, Frantz Foissac, Déborah Hirt, et al.
Journal of Medical Systems|January 28, 2021
Forecasting the Patients Flow at Pediatric Emergency DepartmentsThomas Morzadec, Hélène Chappuy, Naïm Bouazza, et al.
Pageof 18

Showing results (21-30 of 171) with videos related to

Sort By:
Pageof 18
Kidney International|March 1, 2021
Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case-noncase studyLaurent Chouchana, Laure-Hélène Preta, Mylène Tisseyre, et al.
British Journal of Clinical Pharmacology|February 17, 2022
Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273)Laure-Hélène Préta, Adrien Contejean, Francesco Salvo, et al.
Obstetrics and Gynecology|December 1, 2025
In ReplyMathis Collier, Pierre Hannoun, Valérie Cormier-Daire, et al.
Therapie|November 26, 2023
Drug-induced fetal and offspring disorders, beyond birth defectsMargaux Louchet, Mylène Tisseyre, Florentia Kaguelidou, et al.
British Journal of Clinical Pharmacology|May 23, 2023
Azathioprine-induced vanishing bile duct syndrome: The value of early thiopurine metabolism assessmentLaurent Chouchana, Benoit Terris, Philippe Sogni, et al.
Allergy, Asthma & Immunology Research|March 18, 2021
Safety of Omalizumab During Pregnancy and Breast-Feeding With Assessment of Placental Transfer: A Case ReportDoriane Majou, Baptiste Moreira, Clémence Martin, et al.
Journal of the American Academy of Dermatology|May 30, 2021
Drug-induced eosinophilic fasciitis: A dual pharmacovigilance analysisAlexandre Teboul, Laurent Chouchana, Geneviève Durrieu, et al.
Rheumatology (Oxford, England)|October 9, 2021
Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance studyCamille Mettler, Annie-Pierre Jonville-Bera, Aurélie Grandvuillemin, et al.
Current Pharmaceutical Design|March 21, 2019
Methodological Approaches to Evaluate Fetal Drug ExposureNaïm Bouazza, Frantz Foissac, Déborah Hirt, et al.
Journal of Medical Systems|January 28, 2021
Forecasting the Patients Flow at Pediatric Emergency DepartmentsThomas Morzadec, Hélène Chappuy, Naïm Bouazza, et al.
Pageof 18